[ad_1]


Merck’s stock rallied into record territory Wednesday, after the drug giant’s treatment for pulmonary arterial hypertension, Winrevair, was approved by the U.S. Food and Drug Administration.

[ad_2]

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *